Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

61 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Is Prophylactic Splenectomy Necessary for Proximal Advanced Gastric Cancer Invading the Greater Curvature with Clinically Negative Splenic Hilar Lymph Node Metastasis? A Multi-Institutional Cohort Study (YCOG2003).
Sato S, Kunisaki C, Kondo H, Tsuchiya N, Tanaka Y, Takahashi M, Sato K, Kimura J, Ono HA, Makino H, Tamura Y, Kasahara K, Kosaka T, Akiyama H, Endo I. Sato S, et al. Among authors: ono ha. Ann Surg Oncol. 2022 Sep;29(9):5885-5891. doi: 10.1245/s10434-022-11939-w. Epub 2022 Jun 28. Ann Surg Oncol. 2022. PMID: 35763232
The new prognostic score for unresectable or recurrent gastric cancer treated with nivolumab: A multi-institutional cohort study.
Sato S, Oshima Y, Matsumoto Y, Seto Y, Yamashita H, Hayano K, Kano M, Ono HA, Mitsumori N, Fujisaki M, Kunisaki C, Akiyama H, Endo I, Ichikawa Y, Urakami H, Kubo H, Nagaoka S, Shimada H. Sato S, et al. Among authors: ono ha. Ann Gastroenterol Surg. 2021 Jul 13;5(6):794-803. doi: 10.1002/ags3.12489. eCollection 2021 Nov. Ann Gastroenterol Surg. 2021. PMID: 34755011 Free PMC article.
Multicenter phase II study of capecitabine plus cisplatin as first-line therapy for human epidermal growth factor receptor 2-negative advanced gastric cancer: Yokohama Clinical Oncology Group Study YCOG1107.
Sato K, Kunisaki C, Kosaka T, Takagawa R, Takahashi M, Izumisawa Y, Miyamoto H, Sato S, Tanaka Y, Yamaguchi N, Kimura J, Ono HA, Makino H, Akiyama H, Endo I. Sato K, et al. Among authors: ono ha. Cancer Chemother Pharmacol. 2017 Nov;80(5):939-943. doi: 10.1007/s00280-017-3430-6. Epub 2017 Sep 14. Cancer Chemother Pharmacol. 2017. PMID: 28913549 Clinical Trial.
Surgical advantages of reduced-port laparoscopic gastrectomy in gastric cancer.
Kunisaki C, Makino H, Yamaguchi N, Izumisawa Y, Miyamato H, Sato K, Hayashi T, Sugano N, Suzuki Y, Ota M, Tsuburaya A, Kimura J, Takagawa R, Kosaka T, Ono HA, Akiyama H, Endo I. Kunisaki C, et al. Among authors: ono ha. Surg Endosc. 2016 Dec;30(12):5520-5528. doi: 10.1007/s00464-016-4916-8. Epub 2016 May 20. Surg Endosc. 2016. PMID: 27198549
61 results